Steris Plc (NYSE:STE) VP Karen L. Burton sold 3,270 shares of Steris Plc stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $85.70, for a total value of $280,239.00. Following the completion of the sale, the vice president now directly owns 11,807 shares of the company’s stock, valued at approximately $1,011,859.90. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Steris Plc (NYSE STE) traded down 0.40% on Thursday, reaching $86.23. The company’s stock had a trading volume of 369,667 shares. Steris Plc has a one year low of $63.80 and a one year high of $87.49. The stock has a 50-day moving average of $82.90 and a 200-day moving average of $75.45. The stock has a market cap of $7.35 billion, a P/E ratio of 61.68 and a beta of 1.33.

Steris Plc (NYSE:STE) last posted its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping the consensus estimate of $0.80 by $0.05. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. The firm had revenue of $608 million for the quarter, compared to the consensus estimate of $597.66 million. During the same quarter last year, the company earned $0.79 earnings per share. The business’s revenue for the quarter was down 4.8% compared to the same quarter last year. On average, analysts predict that Steris Plc will post $4.06 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 28th. Stockholders of record on Tuesday, August 29th will be paid a $0.31 dividend. The ex-dividend date is Friday, August 25th. This represents a $1.24 annualized dividend and a dividend yield of 1.44%. This is an increase from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s dividend payout ratio (DPR) is 80.00%.

COPYRIGHT VIOLATION WARNING: This report was originally published by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2017/08/17/steris-plc-ste-vp-sells-280239-00-in-stock.html.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Teachers Advisors LLC increased its position in Steris Plc by 9.1% in the fourth quarter. Teachers Advisors LLC now owns 200,351 shares of the medical equipment provider’s stock valued at $13,502,000 after buying an additional 16,717 shares during the period. Louisiana State Employees Retirement System increased its position in Steris Plc by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 21,400 shares of the medical equipment provider’s stock valued at $1,486,000 after buying an additional 300 shares during the period. Diversified Trust Co increased its position in Steris Plc by 7.8% in the first quarter. Diversified Trust Co now owns 3,816 shares of the medical equipment provider’s stock valued at $265,000 after buying an additional 275 shares during the period. Nationwide Fund Advisors increased its position in Steris Plc by 16.2% in the first quarter. Nationwide Fund Advisors now owns 540,723 shares of the medical equipment provider’s stock valued at $37,559,000 after buying an additional 75,379 shares during the period. Finally, NBW Capital LLC increased its position in Steris Plc by 24.0% in the first quarter. NBW Capital LLC now owns 47,312 shares of the medical equipment provider’s stock valued at $3,286,000 after buying an additional 9,170 shares during the period. 92.40% of the stock is currently owned by hedge funds and other institutional investors.

Several brokerages recently weighed in on STE. Raymond James Financial, Inc. lifted their price objective on Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. BidaskClub lowered Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research raised Steris Plc from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. KeyCorp raised Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 price objective for the company in a report on Wednesday, May 3rd. Finally, Wellington Shields lowered Steris Plc from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company has an average rating of “Buy” and an average target price of $86.75.

About Steris Plc

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Insider Buying and Selling by Quarter for Steris Plc (NYSE:STE)

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.